Are you facing limiting resources and experience in CEE markets?

Whether you need market access or business solutions we can help you.

Cecilia Marinova, MD, MBA
Managing Partner

Our vision

Our vision is to provide medical access to programs, diagnosis, treatment and medical solutions in areas of unmet medical needs.

Our commitment

Our commitmemt is lower risk market access scenario & cost effective business solutions.

HOW WE WORK

Medasol offers 3 effective commercial models. Business model solution is based on common preference for responsibility for processes and cost assignments:

1Commercialization via
Royalty Fees

2Commercialization via
Shared Responsibility

3Commercialization via
Consultancy Contract

WHAT WE DO

We transform strategies into business results. We show the option, suggest the best solution and you choose.

What stands behind our expertise:

Implementation of strategic objectives / business results.

Partnership and networking with all stakeholders / integrity.

Experience and understanding/ low risk solution.

Creating new, innovative models for market entrance / business solution.

Market know-how
Opportunity Evaluation
Legal

Regulatory
Logistics & Distribution
Business Model

Size of opportunity
P&R
Strategy

Pricing
Paid Access
P&R Dossier

Assessment of diagnostic and therapeutic setting:
Diagnostic procedures, patient pathways, specialized centers, standard of care, therapeutic gaps and opportunities
Identification, engagement and continued interaction with investigational sites
Identification and establishment of KOL network

Advisory Boards
Scientific communication
Congress symposia, educational events, publications
Medical support for Market Access
Value dossiers, stakeholder engagement, hearings, price negotiations

Scientific product communication
Congress symposia, educational events, publications
Leveraging of KOL network for product support
Strategic Medical messaging
Handling of Medical queries

Marketing support
Information Officer responsibility
Scientific accuracy of all communications
Drug promotion according to applicable law and regulations
Accuracy of SmPC/labeling, packaging material and product listings

We reach out to Key Opinion Leaders in collaboration with medical
We develop a value story for payers in collaboration with medical and health economics experts
We develop pricing strategies for EU/International regions in close collaboration with HQ (CCO/CFO)
We establish contacts with key health-economical and health-political stakeholders
We prepare a pricing and reimbursement roadmap per country
Development of distribution strategies:
- Logisitics (warehousing, physical distribution)
- Order and invoicing processes

We create product/therapy positioning
We develop commercial messages based on phase III data and other publications
We prepare blueprints for commercial organisations (EU/International HQ and country organisations
We set-up customer databases, based on agreed segmentation parameters
We recruit train commercial staff
We develop commercial materials
We set-up commercial KPI/Sales planning and tracking tools

Kick-off pricing and reimbursement processes in various countries
- Price registration
- Submission of value dossiers

We inform stakeholders about product availability, including pricing and order processes
We communicate medical and commercial messages to customers/prescribers
KPI‘s/CRM tracking